© 2021 MJH Life Sciences and Cancer Network. All rights reserved.
© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.
November 14, 2014
In this interview we discuss a patient who experienced regression of BRAF-inhibitor-induced eruptive melanocytic nevi following concomitant addition of a MEK inhibitor.
August 01, 2004
Melanoma incidence and mortality continue to rise unabated in older individuals. Early clinical detection should take into account the different subtypes.